Centre for Cognitive and Neural Systems, University of Edinburgh, EH8 9JZ, Edinburgh, United Kingdom.
J Neurosci. 2010 Apr 7;30(14):4981-9. doi: 10.1523/JNEUROSCI.3140-09.2010.
Weakly tetanized synapses in area CA1 of the hippocampus that ordinarily display long-term potentiation lasting approximately 3 h (called early-LTP) will maintain a longer-lasting change in efficacy (late-LTP) if the weak tetanization occurs shortly before or after strong tetanization of an independent, but convergent, set of synapses in CA1. The synaptic tagging and capture hypothesis explains this heterosynaptic influence on persistence in terms of a distinction between local mechanisms of synaptic tagging and cell-wide mechanisms responsible for the synthesis, distribution, and capture of plasticity-related proteins (PRPs). We now present evidence that distinct CaM kinase (CaMK) pathways serve a dissociable role in these mechanisms. Using a hippocampal brain-slice preparation that permits stable long-term recordings in vitro for >10 h and using hippocampal cultures to validate the differential drug effects on distinct CaMK pathways, we show that tag setting is blocked by the CaMK inhibitor KN-93 (2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)amino-N-(4-chlorocinnamyl)-N-methylbenzylamine) that, at low concentration, is more selective for CaMKII. In contrast, the CaMK kinase inhibitor STO-609 [7H-benzimidazo(2,1-a)benz(de)isoquinoline-7-one-3-carboxylic acid] specifically limits the synthesis and/or availability of PRPs. Analytically powerful three-pathway protocols using sequential strong and weak tetanization in varying orders and test stimulation over long periods of time after LTP induction enable a pharmacological dissociation of these distinct roles of the CaMK pathways in late-LTP and so provide a novel framework for the molecular mechanisms by which synaptic potentiation, and possibly memories, become stabilized.
在海马体 CA1 区,通常情况下,弱刺激引发的突触会表现出持续约 3 小时的长时程增强(称为早期-LTP),如果弱刺激发生在独立但会聚的 CA1 区的另一组突触的强刺激之前或之后不久,那么这种突触效能的持久变化(晚期-LTP)将会维持更长时间。突触标记和捕获假说根据局部突触标记机制和负责可塑性相关蛋白(PRPs)合成、分布和捕获的全细胞机制之间的区别,解释了这种异突触对持久性的影响。我们现在提供的证据表明,不同的钙调蛋白激酶(CaMK)途径在这些机制中发挥了可分离的作用。我们使用海马脑切片制备物,该制备物允许体外进行稳定的长时程记录超过 10 小时,并使用海马培养物验证了不同药物对不同 CaMK 途径的差异作用,我们表明,标签设置被 CaMK 抑制剂 KN-93(2-[N-(2-羟乙基)]-N-(4-甲氧基苯磺酰基)氨基-N-(4-氯肉桂基)-N-甲基苯甲胺)阻断,该抑制剂在低浓度时对 CaMKII 更具选择性。相比之下,CaMK 激酶抑制剂 STO-609(7H-苯并咪唑并[2,1-a]苯并[de]异喹啉-7-酮-3-羧酸)特异性限制了 PRPs 的合成和/或可用性。使用顺序强刺激和弱刺激的三通路协议,以及在 LTP 诱导后长时间进行测试刺激,具有强大的分析能力,能够对这些不同 CaMK 途径在晚期-LTP 中的作用进行药理学分离,从而为突触增强以及可能的记忆稳定的分子机制提供了新的框架。